ImageneBio Grants Stock Awards to Three New Hires Under Nasdaq Rule
ImageneBio issued RSUs and stock options to three new non-executive employees as employment inducements under Nasdaq Listing Rule 5635(c)(4).
ImageneBio, Inc. (Nasdaq: IMA) disclosed Thursday that its Board's Compensation Committee approved equity inducement grants to three newly hired non-executive employees, effective September 30, 2026, under Nasdaq Listing Rule 5635(c)(4), which permits companies to issue equity as a material inducement to attract new talent without a shareholder vote.
The awards consist of 90,775 restricted stock units and 32,725 non-qualified stock options. Both grant types are governed by the company's 2025 Equity Inducement Plan and corresponding award agreements, the San Diego-based biotechnology firm said in a regulatory disclosure.
Read more Class Action Filed Against Fluence Energy Over Alleged Investor Harm →
Inducement grants of this kind are a common mechanism among publicly traded companies, particularly in the life sciences sector, allowing firms to compete for specialized talent by offering equity compensation that vests over time. The Nasdaq rule provides a narrow exemption that bypasses the typical requirement for shareholder approval of equity issuances.
ImageneBio did not disclose the identities of the three employees, their roles, or the vesting schedules attached to the awards. The company has not issued additional commentary beyond the formal announcement.
Continue reading at GlobeNewswire - Industry News on Financial Services.
